Zydus is one of the leading pharmaceutical companies, with the largest specialized healthcare team of over 150 medical marketing & sales personnel and has an annual revenue of USD 21 Million.

Our group started its journey in the Sri Lankan pharma market with Sunshine Healthcare Ltd., almost three decades ago. We then joined in a partnership with Hemas Holdings in 2000. In 2015, we became the No.1 pharmaceutical company of Sri Lanka as per IMS MAT’2015.

While reaching every corner of the country, we cover the entire spectrum of healthcare. Offering a wide range of high quality, affordable medicines that span across different therapeutic segments. Our product range consists of prescription based pharmaceuticals – that are supplied to various government hospitals and state run pharmacies, private hospitals and retail pharmacies as well as doctors who dispense drugs as part of their private practice. We hold the leadership position in Cardiovascular, Gynecology, Gastrointestinal & Pain Management segments and we are also present in many of the therapeutic segments such as Respiratory, Neuro-psychiatric, Subfertility and Oncology, as well as in Biosimilars & Vaccines.

Earlier our presence was only in oral solids but in 2016, we entered the Biologics market with the launch of Pegfilgrastim in the country. Most recently, we introduced neuropsychiatric drugs for Epilepsy and Depression. Our brands (Atorva, Zycel, Pantodac, Kalzana and Ferup), feature amongst the top pharma/prescription brands in the country.

Headquartered in Colombo, Zydus Lanka Pvt Ltd. is a subsidiary of Cadila Healthcare Ltd. we are dedicated to helping people in Sri Lanka, enable them to live healthier lives through a diverse range of science based healthcare products & branded-generic pharmaceuticals.